Last reviewed · How we verify
NCT06672198: Erac
ERAC Protocol in Elective Cesarean Surgery
trial testing ERAC protocol in Cesrean Delivery in 333 participants. Completed in 1 September 2022.
1 December 2021
Quick facts
| Lead sponsor | Gonca Karatas Baran |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 333 |
| Start date | 1 December 2021 |
| Primary completion | 1 December 2021 |
| Estimated completion | 1 September 2022 |
| Sites | 1 location across Turkey (Türkiye) |
Drugs / interventions tested
- ERAC protocol
Conditions studied
- Cesrean Delivery — all drugs for Cesrean Delivery →
- Enhanced Recovery After Surgery — all drugs for Enhanced Recovery After Surgery →
Sponsor
Gonca Karatas Baran
Who can join
Eligibility, female only, with Cesrean Delivery or Enhanced Recovery After Surgery. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This descriptive prospective study was conducted between 01/12/2021-01/09/2022. The sample of the study consisted of 333 women who underwent elective cesarean section (CS). Nurse observation form, anesthesia follow-up form, patient file and verbal expressions of women were used to collect data. Number, percentage, mean and standard deviation were used as descriptive statistics.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT06672198
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other Gonca Karatas Baran trials
Trials by the same sponsor.
- NCT05486663 — Tactile/kinesthetic Stimulus Program · NA · recruiting
- NCT05358392 — "Effect of Emotional Freedom Technique " · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06672198 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Gonca Karatas Baran
- Last refreshed: 22 November 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06672198.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing